Dow Jones reports the U.S. FDA said it's requested additional information from makers of certain asthma drugs as part of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE